Adoption Scenario of Vitamin D Ingredients Market to Remain Positive Through 2026
In this report, Research Report Insights delivers key insights on the global Vitamin D Ingredients market in its published report, titled “Global Vitamin D Ingredients Market: Global Industry Analysis, size, sales and Forecast by 2026.” In terms of revenue, “The global market for vitamin D ingredients, which is presently valued over US$ 1.2 billion, will surge at a healthy CAGR of 11.1% and bring in revenues worth over US$ 3.5 billion by the end of 2026.”
The market is segmented based on product type, source type, form type, application type and region. Based on product type, the market is sub-segmented into Vitamin D3 and Vitamin D2. Among all the material type segment, Vitamin D3 segment is expected to account for the highest market share, followed by Vitamin D2 segment over the forecast period. The Vitamin D2 material type segment is expected to register a significant CAGR of 8.16% during the forecast period in terms of value. The Vitamin D3 segment is projected to register the highest CAGR of 12.01% over the forecast period. The factors fuelling demand for Vitamin D Ingredients is the development in pharmaceutical industry and easy regulations for Vitamin D Ingredients globally.
Request For Report Sample: https://www.researchreportinsights.com/report/sample/110114815/Vitamin-D-Ingredients-Market
To provide in-depth insights on the pattern of demand for Vitamin D Ingredients, the market is segmented on the basis of form such as Powder form, Resin form and Liquid form. The Powder form segment is projected to grow at a significant CAGR of 12.42% over the forecast period in terms of value. The market has been segmented by source type which includes fish, milk, Plants, Fruits & Vegetables, Eggs, Animals and Others (Microalgae, fungi, yeast, etc.). Fish segment is anticipated to be most attractive segment in terms of CAGR over the forecast period. Fish segment held a significant market share of 62.8% in 2016. The growing concern towards the decline in fish population issues create environmental concern which is expected to obstruct the growth of global Vitamin D Ingredients market. The market is segmented by application type which includes Pharmaceuticals, foods, beverages, cosmetics, Animal feeds & pet foods and others.
A key trend defining the market is that Vitamin D Ingredients service provider are shifting their focus towards plants sources due to increasing demand of vegetarian products. Manufacturers are shifting their focus towards Vitamin D2 and Vitamin D2 analog in order to grab a piece of the pie. Moreover, the Vitamin D Ingredients market is continuously shifting their focus towards make to order approach which not only provide effective protection to the product but removes the issues related to selling inventory.
Thriving Pharmaceutical Industry to Drive Growth of the Global Vitamin D Ingredients Market: RRI
This report assesses trends driving growth of each segment on the global level and offers potential takeaways that could prove substantially useful to Vitamin D Ingredients manufacturers looking to enter the market. The North America market dominated the Vitamin D Ingredients market, accounting for maximum revenue share of the market in 2016. Collectively, Western Europe and APEJ markets accounted for over 17.2% revenue share of the global Vitamin D Ingredients market in 2016. Among the emerging markets, Asia Pacific excluding Japan is estimated to exhibit a significant CAGR of 11.6% over the forecast period, followed by Middle East & Africa market, due to the growing Vitamin D deficiency among individuals.
Request Report Discount: https://www.researchreportinsights.com/report/discount/110114815/Vitamin-D-Ingredients-Market
Some of the key players in the global Vitamin D Ingredients market include BASF SE, Dishman Netherlands B.V., KONINKLIJKE DSM N.V., Zhejiang Garden Bio-Chemical High-Tech Company Limited, Schiff Nutrition International, Inc. (Reckitt Benckiser), Barr Pharmaceuticals (Teva Pharmaceuticals), GLAXOSMITHKLINE Plc., Fermenta Biotech Ltd, Lycored Limited and Polymed Therapeutics. In this report, we have discussed individual strategies followed by these companies in terms of enhancing their product portfolio, creating new marketing techniques, mergers and acquisitions. The ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and company share collectively.